Enzymatic and Motor Properties of Myosin 19

Information

  • Research Project
  • 8517048
  • ApplicationId
    8517048
  • Core Project Number
    K01CA160667
  • Full Project Number
    5K01CA160667-03
  • Serial Number
    160667
  • FOA Number
    PAR-09-052
  • Sub Project Id
  • Project Start Date
    8/2/2011 - 13 years ago
  • Project End Date
    2/29/2016 - 8 years ago
  • Program Officer Name
    SOYOMBO-SHOOLA, ABIGAIL ADEBISI
  • Budget Start Date
    8/1/2013 - 11 years ago
  • Budget End Date
    2/29/2016 - 8 years ago
  • Fiscal Year
    2013
  • Support Year
    03
  • Suffix
  • Award Notice Date
    7/17/2013 - 11 years ago
Organizations

Enzymatic and Motor Properties of Myosin 19

DESCRIPTION (provided by applicant): The long-term goal of this research project is to understand the enzymatic properties, motor properties, and cellular functions of myosin XIX (Myo19), a molecular motor protein involved in the transport and localization of mitochondria, an organelle central to multiple cellular processes. Mitochondrial dynamics have been shown to be partially actin-based, and mutations in other genes involved in mitochondrial dynamics lead to human diseases. Additionally, microarray analyses indicate that Myo19 expression is increased in certain cancers, compared to normal tissues. Previous studies show that Myo19 plays a role in mitochondrial motility in cultured cells as expression of GFP-tagged Myo19 constructs alters mitochondrial dynamics in a pulmonary cancer cell line and in a cultured neuronal cell line. Taken together, analysis of the Myo19 protein sequence and analysis of the effect of GFP-Myo19 expression in cultured cells lead to the hypothesis that Myo19 plays a role in mitochondrial dynamics, as it contains a conserved myosin motor domain and interacts with mitochondria via its tail domain. We will use both Myo19 knock-down and overexpression of functional and non-functional Myo19 constructs in cell culture models of cell division and apoptosis to determine what role Myo19 may play in each of those processes. Expression and purification of Myo19 motor domain will allow for a complete in vitro analysis of the rate and equilibrium constants associated with the motor properties of Myo19. Additionally, purified protein will be used to directly examine the motor properties of Myo19 using an in vitro actin sliding filament motility assay system. Examination of both the enzymatic and motor characteristics of Myo19 in vitro will allow the determination of the mechanism by which Myo19 motor activity generates force, and determination of factors that may regulate its function in vivo. By examining the functional roles, enzymatic properties, and motor properties, of Myo19, these proposed studies will further our understanding of mitochondrial dynamics in health and disease.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    K01
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    103125
  • Indirect Cost Amount
    8250
  • Total Cost
    111375
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    398
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NCI:111375\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    NCI
  • Study Section Name
    Subcommittee I - Transistion to Independence
  • Organization Name
    UNIVERSITY OF RICHMOND
  • Organization Department
    BIOLOGY
  • Organization DUNS
    056915069
  • Organization City
    RICHMOND
  • Organization State
    VA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    231730001
  • Organization District
    UNITED STATES